Status:
COMPLETED
Serratus Anterior Plane Block and Serratus Anterior Plane Block + Continuous Wound Infiltration With Catheter
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Postoperative Pain
Minimal Invasive Cardiac Surgery
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A total of 46 patients scheduled to undergo elective coronary artery bypass surgery via a minimally invasive technique will be included in the study. In the preoperative period, patients will be rando...
Detailed Description
SAPB :Using ultrasound guidance, the needle is advanced in-plane at approximately 45° toward the fifth rib. For the superficial SAPB, the local anesthetic is injected anteriorly to the serratus anteri...
Eligibility Criteria
Inclusion
- Women and men aged 18-75,
- ASA I-II-III risk group,
- Body mass index between 18-35,
- who will undergo coronary artery bypass surgery with minimally invasive cardiac surgery method
Exclusion
- Those under 18 and over 75
- Those with advanced comorbidities
- Those with ASA score IV
- Those with a history of bleeding diathesis and those using drugs that cause bleeding disorders
- Patients with an infection in the area where the block will be performed
- Patients who are allergic to the local anesthetic agent to be used
- Patients with a body mass index (BMI) under 18 and over 35 will be excluded from the study.
- Withdrawal criteria:
- Patients who want to leave the study group
- Patients who develop surgical complications will be removed from the study.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06971432
Start Date
April 1 2024
End Date
December 15 2024
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Bilkent City Hospital
Ankara, Çankaya, Turkey (Türkiye), 06800